Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians

Holger J Schünemann1, Deborah Cook2, Gordon Guyatt2

  • 1From the Italian National Cancer Institute Regina Elena, Rome, Italy.

Chest
|July 24, 2008
PubMed

Insights

The American College of Chest Physicians developed evidence-based guidelines for antithrombotic and thrombolytic therapy. This rigorous process ensures recommendations are transparent, methodologically sound, and clinically relevant.

Area of Science:

  • Medical Guidelines
  • Evidence-Based Medicine
  • Thrombosis Management

Background:

  • The American College of Chest Physicians (ACCP) convened experts to update its evidence-based guidelines.
  • Previous guidelines have guided clinical practice in antithrombotic and thrombolytic therapy.

Purpose of the Study:

  • To develop the eighth edition of ACCP evidence-based guidelines on antithrombotic and thrombolytic therapy.
  • To ensure recommendations are transparent, methodologically sound, and clinically relevant.

Main Methods:

  • Expert panel formation including researchers and methodologists.
  • Systematic literature searches and rigorous assessment of study quality.
  • Explicit definition of clinical questions, eligibility criteria, and grading of recommendations.

Main Results:

  • Guidelines organized into chapters linking evidence to recommendations.
  • Consideration of resource allocation and economic implications.
  • Explicit statement of values and preferences influencing recommendations.

Conclusions:

  • The methodology establishes a robust evidence-based approach for guideline development.
  • The updated guidelines provide a clear link between evidence and clinical recommendations.
  • The process emphasizes transparency, quality assessment, and consideration of patient values.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...